"There is new hope for people with an aggressive type of breast cancer, as an immunotherapy trial shows for the first time that lives can be extended in people with triple-negative breast cancer." Read more...
First immunotherapy success for triple-negative breast cancer. Medical Xpress.
October 21, 2018, Queen Mary, University of London
